Cargando…

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma

BACKGROUND: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble ICC and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sammon, Jennifer, Fischer, Sandra, Menezes, Ravi, Hosseini-Nik, Hooman, Lewis, Sara, Taouli, Bachir, Jhaveri, Kartik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830053/
https://www.ncbi.nlm.nih.gov/pubmed/29486800
http://dx.doi.org/10.1186/s40644-018-0142-z
_version_ 1783302938061438976
author Sammon, Jennifer
Fischer, Sandra
Menezes, Ravi
Hosseini-Nik, Hooman
Lewis, Sara
Taouli, Bachir
Jhaveri, Kartik
author_facet Sammon, Jennifer
Fischer, Sandra
Menezes, Ravi
Hosseini-Nik, Hooman
Lewis, Sara
Taouli, Bachir
Jhaveri, Kartik
author_sort Sammon, Jennifer
collection PubMed
description BACKGROUND: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble ICC and the aim of our study was to examine the differential MRI features of cHCC-CC and ICC with emphasis on enhancement pattern observations of gadolinium enhanced MRI. METHODS: Institutional review board approval with consent waiver was obtained for this retrospective bi-centric study. Thirty-three patients with pathologically proven cHCC-CC and thirty-eight patients with pathologically proven ICC, who had pre-operative MRI, were identified. MRI images were analyzed for tumor location and size, T1 and T2 signal characteristics, the presence/absence of: cirrhosis, intra-lesional fat, hemorrhage/hemosiderin, scar, capsular retraction, tumor thrombus, biliary dilatation, degree of arterial enhancement, enhancement pattern, pseudocapsule and washout. Associations between MRI features and tumor type were examined using the Fisher’s exact and chi-square tests. RESULTS: Strong arterial phase enhancement and the presence of: washout, washout and progression, intra-lesional fat and hemorrhage were all strongly associated with cHCC-CC (P < 0.001). While cHCC-CC had a varied enhancement pattern, the two most common enhancement patterns were peripheral persistent (n = 6) and heterogeneous hyperenhancement with washout (n = 6), compared to ICC where the most common enhancement patterns were peripheral hypoenhancement with progression (n = 18) followed by heterogeneous hypoenhancement with progression (n = 14) (P < 0.001). CONCLUSION: The cHCC-CC enhancement pattern seems to more closely resemble HCC with the degree of arterial hyperenhancement and the presence of washout being valuable in differentiating cHCC-CC from ICC. However the presence of washout and progression, in the same lesion or a predominantly peripheral /rim hyperenhancing mass were also seen as important features that should alert the radiologist to the possibility of a cHCC-CC.
format Online
Article
Text
id pubmed-5830053
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58300532018-03-05 MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma Sammon, Jennifer Fischer, Sandra Menezes, Ravi Hosseini-Nik, Hooman Lewis, Sara Taouli, Bachir Jhaveri, Kartik Cancer Imaging Research Article BACKGROUND: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver tumor, which has overlapping imaging features with mass forming intra-hepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC). Previous studies reported imaging features more closely resemble ICC and the aim of our study was to examine the differential MRI features of cHCC-CC and ICC with emphasis on enhancement pattern observations of gadolinium enhanced MRI. METHODS: Institutional review board approval with consent waiver was obtained for this retrospective bi-centric study. Thirty-three patients with pathologically proven cHCC-CC and thirty-eight patients with pathologically proven ICC, who had pre-operative MRI, were identified. MRI images were analyzed for tumor location and size, T1 and T2 signal characteristics, the presence/absence of: cirrhosis, intra-lesional fat, hemorrhage/hemosiderin, scar, capsular retraction, tumor thrombus, biliary dilatation, degree of arterial enhancement, enhancement pattern, pseudocapsule and washout. Associations between MRI features and tumor type were examined using the Fisher’s exact and chi-square tests. RESULTS: Strong arterial phase enhancement and the presence of: washout, washout and progression, intra-lesional fat and hemorrhage were all strongly associated with cHCC-CC (P < 0.001). While cHCC-CC had a varied enhancement pattern, the two most common enhancement patterns were peripheral persistent (n = 6) and heterogeneous hyperenhancement with washout (n = 6), compared to ICC where the most common enhancement patterns were peripheral hypoenhancement with progression (n = 18) followed by heterogeneous hypoenhancement with progression (n = 14) (P < 0.001). CONCLUSION: The cHCC-CC enhancement pattern seems to more closely resemble HCC with the degree of arterial hyperenhancement and the presence of washout being valuable in differentiating cHCC-CC from ICC. However the presence of washout and progression, in the same lesion or a predominantly peripheral /rim hyperenhancing mass were also seen as important features that should alert the radiologist to the possibility of a cHCC-CC. BioMed Central 2018-02-27 /pmc/articles/PMC5830053/ /pubmed/29486800 http://dx.doi.org/10.1186/s40644-018-0142-z Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sammon, Jennifer
Fischer, Sandra
Menezes, Ravi
Hosseini-Nik, Hooman
Lewis, Sara
Taouli, Bachir
Jhaveri, Kartik
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_full MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_fullStr MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_full_unstemmed MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_short MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
title_sort mri features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830053/
https://www.ncbi.nlm.nih.gov/pubmed/29486800
http://dx.doi.org/10.1186/s40644-018-0142-z
work_keys_str_mv AT sammonjennifer mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT fischersandra mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT menezesravi mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT hosseininikhooman mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT lewissara mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT taoulibachir mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma
AT jhaverikartik mrifeaturesofcombinedhepatocellularcholangiocarcinomaversusmassformingintrahepaticcholangiocarcinoma